FDA Inspection 1179721 — CG Oncology, Inc.
The FDA completed an inspection of CG Oncology, Inc. on Sep 2, 2022 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 2, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Dallas, TX (United States)
Additional Details
Sponsor, Contract Research Organization